Form 8-K - Current report:
SEC Accession No. 0001493152-20-021106
Filing Date
2020-11-12
Accepted
2020-11-12 16:30:10
Documents
3
Period of Report
2020-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 30270
2 ex99-1.htm EX-99.1 166523
3 ex99-1_001.jpg GRAPHIC 1951
  Complete submission text file 0001493152-20-021106.txt   200852
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 201307189
SIC: 2835 In Vitro & In Vivo Diagnostic Substances